Vistagen Therapeutics (VTGN) Research & Development (2011 - 2026)
Vistagen Therapeutics' Research & Development was $10.91 million in fiscal Q1 2027 (quarter ended Jun 30, 2026), down 6.6% from $11.68 million a year earlier and down 16.5% from the prior quarter.
Vistagen Therapeutics (VTGN) Research & Development (2011 - 2026) Analysis & Trends
On a trailing twelve-month basis, Vistagen Therapeutics' Research & Development was $54.1 million through Jun 30, 2026, up 24.6% year-over-year; for FY2026 (ended Mar 31, 2026), it was $54.97 million, up 39.6% from FY2025.
- Research & Development shows a five-year compound annual growth rate of 35.7% (FY2021 to FY2026).
- In earlier fiscal years, Research & Development was $39.38 million in FY2025 (+96.7%), $20.02 million in FY2024 (-54.9%), $44.38 million in FY2023 (+25.3%) and $35.41 million in FY2022 (+196.9%).
- The fiscal Q1 2027 figure marks the lowest quarterly Research & Development since fiscal Q4 2025.
- Compared with a year earlier, Research & Development was higher in seven of the last eight quarters, with growth averaging 63.4%.
- The best year-over-year quarter for Research & Development over five years was fiscal Q2 2022 (growth of 321.4%); the worst was fiscal Q1 2024 (a decline of 72.6%).
- Per Business Quant data, VTGN's Research & Development in the three fiscal quarters before Q1 2027 was $13.06 million (Q4 2026), $14.22 million (Q3 2026) and $15.92 million (Q2 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Vistagen Therapeutics | 13.76 Mn | 13.76 Mn | - | 10.91 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.91 Mn |
| Mar 31, 2026 | 13.06 Mn |
| Dec 31, 2025 | 14.22 Mn |
| Sep 30, 2025 | 15.92 Mn |
| Jun 30, 2025 | 11.68 Mn |
| Mar 31, 2025 | 10.21 Mn |
| Dec 31, 2024 | 11.31 Mn |
| Sep 30, 2024 | 10.22 Mn |
| Jun 30, 2024 | 7.65 Mn |
| Mar 31, 2024 | 7.44 Mn |
| Dec 31, 2023 | 4.54 Mn |
| Sep 30, 2023 | 3.85 Mn |
| Jun 30, 2023 | 4.20 Mn |
| Mar 31, 2023 | 9.34 Mn |
| Dec 31, 2022 | 6.85 Mn |
| Sep 30, 2022 | 12.89 Mn |
| Jun 30, 2022 | 15.29 Mn |
| Mar 31, 2022 | 12.23 Mn |
| Dec 31, 2021 | 7.78 Mn |
| Sep 30, 2021 | 9.94 Mn |
Vistagen Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=VTGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "VTGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=VTGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();